RGLAX
Price
$24.30
Change
+$0.03 (+0.12%)
Updated
May 8 closing price
Net Assets
15.86B
RWIBX
Price
$63.96
Change
+$0.18 (+0.28%)
Updated
May 8 closing price
Net Assets
124.44B
Ad is loading...

RGLAX vs RWIBX

Header iconRGLAX vs RWIBX Comparison
Open Charts RGLAX vs RWIBXBanner chart's image
American Funds Global Insight R-1
Price$24.30
Change+$0.03 (+0.12%)
VolumeN/A
Net Assets15.86B
American Funds Capital World Gr&Inc R2
Price$63.96
Change+$0.18 (+0.28%)
VolumeN/A
Net Assets124.44B
RGLAX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGLAX vs. RWIBX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGLAX is a StrongBuy and RWIBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 124B vs. RGLAX (15.9B). RWIBX pays higher dividends than RGLAX: RWIBX (0.91) vs RGLAX (0.31). RGLAX was incepted earlier than RWIBX: RGLAX (6 years) vs RWIBX (23 years). RGLAX (1.52) and RWIBX (1.51) have similar cost to investors . RWIBX is a more actively managed with annual turnover of: 27.00 vs. RGLAX (21.00). RGLAX (250) and RWIBX (250) have matching initial minimum investment requirements. RGLAX annual gain was more profitable for investors over the last year : 7.99 vs. RWIBX (1.43). RGLAX return over 5 years is better than : 61.73 vs. RWIBX (46.85).
RGLAXRWIBXRGLAX / RWIBX
Total Expense Ratio1.521.51101%
Annual Report Gross Expense Ratio1.521.51101%
Fund Existence6 years23 years-
Gain YTD4.0242.376169%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets15.9B124B13%
Annual Yield % from dividends0.310.9134%
Returns for 1 year7.991.43560%
Returns for 3 years36.7928.48129%
Returns for 5 years61.7346.85132%
Returns for 10 yearsN/A37.12-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CNCR9.120.27
+3.05%
Range Cancer Therapeutics ETF
JVAL41.010.48
+1.19%
JPMorgan US Value Factor ETF
GDV23.980.10
+0.42%
Gabelli Dividend & Income Trust (The)
BRLN51.40N/A
N/A
iShares Floating Rate Loan Active ETF
PHYD50.96-0.02
-0.03%
Putnam ESG High Yield ETF